WEL · Integrated Wellness Acquisition Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $421.0K | $140.3K | $405.7K | - | $558.2K | $602.1K | $560.6K | - | $412.1K | $719.0K |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($421.0K) | ($140.3K) | ($405.7K) | - | ($558.2K) | ($602.1K) | ($560.6K) | - | ($412.1K) | ($719.0K) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($302.6K) | ($24.4K) | ($292.5K) | - | ($24.5K) | ($78.4K) | ($37.1K) | - | $344.1K | $513.1K |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $0 | $4.0K | $4.2K | $5.1K | $5.3K | $5.5K | $7.4K | $7.6K | $12.0K | $11.2K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $480.5K | $424.5K | $436.1K | $416.3K | $405.0K | $433.4K | $387.7K | $348.3K | $266.0K | $159.9K |
| Current Assets | $2.6K | $6.4K | $6.5K | $6.5K | $47.7K | $105.9K | $44.4K | $7.6K | $35.8K | $147.3K |
| Total Assets | $15.05M | $14.77M | $14.50M | $14.22M | $50.35M | $49.49M | $48.53M | $47.47M | $59.09M | $57.97M |
| Current Liabilities | $8.67M | $8.12M | $7.85M | $7.32M | $6.79M | $5.94M | $4.94M | $4.11M | $3.54M | $2.76M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $12.70M | $12.15M | $11.88M | $11.34M | $10.81M | $9.97M | $8.96M | $8.13M | $7.57M | $6.79M |
| Stockholders' Equity | ($12.69M) | ($12.14M) | ($11.87M) | ($11.34M) | ($10.77M) | ($9.86M) | ($8.92M) | ($8.13M) | ($7.53M) | ($6.64M) |
| Retained Earnings | ($12.69M) | ($12.14M) | ($11.87M) | ($11.34M) | ($10.77M) | ($9.86M) | ($8.92M) | ($8.13M) | ($7.53M) | ($6.64M) |
Cash Flow
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $60.6K | - | - | - | $334.8K | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | $211.7K | - | - | - | $688.5K | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -2.0% | -0.2% | -2.0% | - | -0.0% | -0.2% | -0.1% | - | 0.6% | 0.9% |
| Return on equity | 2.4% | 0.2% | 2.5% | - | 0.2% | 0.8% | 0.4% | - | -4.6% | -7.7% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | 0.05 |
| Quick ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | 0.05 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -1.19 | -1.22 | -1.22 | -1.25 | -4.68 | -5.02 | -5.44 | -5.84 | -7.85 | -8.73 |
| Liabilities / Assets | 0.84 | 0.82 | 0.82 | 0.80 | 0.21 | 0.20 | 0.18 | 0.17 | 0.13 | 0.12 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 24.6% | 76.7% | 27.6% | - | -35.5% | 16.3% | 48.7% | - | -100.5% | -159.2% |
| Net income growth (YoY) | -1136.6% | 68.9% | -687.8% | - | - | - | - | - | 213.4% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -17.9% | -23.1% | -33.1% | -39.5% | -43.0% | -48.6% | -54.8% | -131.0% | -141.6% | -128.0% |
Peer comparison
Same SIC group: Retail-Nonstore Retailers
Comparing Integrated Wellness Acquisition Corp against the 3 most active filers in the same SIC group.